Literature DB >> 16462040

MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese.

Tatsuya Osuga1, Toshiyuki Sakaeda, Tsutomu Nakamura, Toshio Yamada, Tatsuya Koyama, Takao Tamura, Nobuo Aoyama, Noboru Okamura, Masato Kasuga, Katsuhiko Okumura.   

Abstract

Recently, a silent polymorphism of C3435T of the MDR1 gene, encoding the multidrug resistant transporter MDR1/P-glycoprotein, has been found to be associated with susceptibility to ulcerative colitis (UC), but this remains controversial. This study was conducted to find a possible reason for the discrepancies, and it was suggested that the age of onset was important for the association, namely, C3435T was predictive of susceptibility to later onset UC, but not for early onset UC. Linkage disequilibrium of C3435T with T-129C, C1236T and G2677A, T was suggested to be altered in UC, but the analysis of their haplotype provided no advantage in terms of prediction over that with only C3435T. The effect of C3435T on susceptibility could not be explained by that on mRNA expression in rectal mucosa, but it was greater in the C(3435)-noncarriers in the early onset group, allowing the individualization of steroid-based pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16462040     DOI: 10.1248/bpb.29.324

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Dhandapani Kayathiri; Subramanian Rajan; Deepak Gopal Shewade; Steven Aibor Dkhar; Sajjanavar Manjunath; Prayaga Ushakiran; Gangadharan Reneega; Kukreti Ritushree; Chandrasekaran Adithan
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

Review 2.  Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.

Authors:  Tristan M Sissung; Sarah M Troutman; Tessa J Campbell; Heather M Pressler; Hyeyoung Sung; Susan E Bates; William D Figg
Journal:  Discov Med       Date:  2012-01       Impact factor: 2.970

Review 3.  CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.

Authors:  Jia-Jun Zhao; Di Wang; Hui Yao; Da-Wei Sun; Hong-Yu Li
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

Review 4.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 5.  A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.

Authors:  King Leung Fung; Michael M Gottesman
Journal:  Biochim Biophys Acta       Date:  2009-03-11

6.  Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease.

Authors:  T Fiedler; C Büning; W Reuter; G Pitre; E Gentz; H H Schmidt; J Büttner; J Ockenga; T Gerloff; C Meisel; H Lochs; I Roots; K Köpke; A Johne
Journal:  Eur J Clin Pharmacol       Date:  2007-07-31       Impact factor: 2.953

7.  ABCB1 single nucleotide polymorphisms in the Brazilian population.

Authors:  Marcos Antonio Mauricio Scheiner; Arthur Motta Damasceno; Raquel Ciuvalschi Maia
Journal:  Mol Biol Rep       Date:  2009-05-13       Impact factor: 2.316

Review 8.  Characteristics of Japanese inflammatory bowel disease susceptibility loci.

Authors:  Yoshiaki Arimura; Hiroyuki Isshiki; Kei Onodera; Kanna Nagaishi; Kentaro Yamashita; Tomoko Sonoda; Takayuki Matsumoto; Atsushi Takahashi; Masakazu Takazoe; Keiko Yamazaki; Michiaki Kubo; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2013-08-13       Impact factor: 7.527

9.  MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease.

Authors:  Dragana Mijac; Irena Vukovic-Petrovic; Vera Mijac; Vladimir Perovic; Natasa Milic; Srdjan Djuranovic; Daniela Bojic; Dragan Popovic; Djordje Culafic; Miodrag Krstic; Goran Jankovic; Vera Pravica; Milos Markovic
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.